CASI Pharmaceuticals (CASIF) Debt Ratio (2021 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Debt Ratio came in at 0.75 in Q4 2025, up 118.42% YoY from 0.34 in Q4 2024, and up 118.42% on a QoQ basis from 0.34 in Q4 2024.
CASI Pharmaceuticals (CASIF) Debt Ratio (2021 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 5 years of Debt Ratio data on file, last reported at 0.75 in Q4 2025.
- Quarterly Debt Ratio rose 118.42% year-over-year to 0.75 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.75 (up 118.42% YoY) and the FY2025 annual result came in at 0.75, up 118.42% from the prior year.
- Debt Ratio improved to 0.75 in Q4 2025, from 0.34 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 360145.11 in Q2 2024 to a low of 0.1 in Q4 2021.
- A 5-year average of 51485.4 and a median of 0.34 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio jumped 204267.03% — and 2024, when it plunged 99.86%.
- Tracing CASIF's Debt Ratio over 5 years: stood at 0.1 in 2021, then rose by 28.5% to 0.12 in 2022, then jumped by 204267.03% to 251.04 in 2023, then sank by 99.86% to 0.34 in 2024, then jumped by 118.42% to 0.75 in 2025.
- The last three Debt Ratio figures came in at 0.75 (Q4 2025), 0.34 (Q4 2024), and 360145.11 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.47 |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | 0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.75 |
| Dec 31, 2024 | 0.34 |
| Jun 30, 2024 | 360,145.11 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 251.04 |
| Dec 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.10 |